A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

Clinical trial NCT02026271 · COMPLETED

Trial details

NCT number: NCT02026271
Sponsor: Alaunos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Glioblastoma Multiforme Anaplastic Oligoastrocytoma

Start date: 2015-06-01
Primary completion: 2019-08-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.